This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Therapeutic Options for Achieving Realistic Management Goals in your IBS Patients: An Update for Primary Care

Therapeutic Options for Achieving Realistic Management Goals in your IBS Patients: An Update for Primary Care

Format

Clinical Review

Time to Complete

1.25 hours

Released

January 30, 2018

Expires

January 29, 2019
Add to Queue


Maximum Credits

1.25 / AMA PRA Category 1 CreditTM
1.25 / CNE Contact Hours (1.25 pharmacology credits)

Accredited Provider



Provided by Boston University School of Medicine (BUSM)

Commercial Supporter

This activity is supported by independent educational grants from Allergan, Ironwood Pharmaceuticals Inc., and Salix Pharmaceuticals Inc.

Program Description

Irritable bowel syndrome (IBS) is a highly prevalent chronic GI disorder characterized by abdominal pain and altered bowel habits, and may present with either constipation or diarrhea or mixed bowel habits. Specifically, the disease burden of patients with IBS relates to a substantial reduction of quality of life and increased health care utilization with subsequent economic burden as well. Recently, the publication of the Rome IV clinical criteria has enabled providers to make a positive diagnosis of IBS by applying symptom-based criteria with little additional testing necessary to ascertain the diagnosis of IBS. There is a great need to disseminate this new guidance to practicing providers in order to close this knowledge gap and empower healthcare providers in the diagnosis and management of patients with IBS. Our program will aim to provide education in these areas in order to provide healthcare workers with the most effective tools to diagnose IBS correctly and reduce the disease burden.

Intended Audience

Primary care clinicians, including physicians, physician assistants, nurse practitioners, nurses and others who diagnose, treat, and manage patients with IBS

Educational Objectives

After completing this activity, the participant will be better able to:

  • Identify symptom criteria for the diagnosis of irritable bowel syndrome (IBS) and its subtypes by eliciting a thorough patient history and applying clinical symptom criteria
  • Implement available screening and diagnostic tools for the diagnosis of IBS and recognize indications for referral to specialist care
  • Articulate the range of treatment options (both pharmacologic and non-pharmacologic therapies) for patients with IBS
  • Interpret consensus guidelines for the management of IBS
  • Summarize evidence-based guidelines for effective monitoring of patients with IBS
  • Establish strategies to improve communication between patients and healthcare providers concerning their symptoms of IBS and its management in order to improve outcomes

Conflict Of Interest Disclosure Policy

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

Horst Christian Weber, MD
Course Director
Department of Medicine, Gastroenterology
Boston Medical Center
Assistant Professor of Medicine
Boston University School of Medicine
Boston, MA

Associated Chief and Clinical Director,
Gastroenterology and Hepatology
VA Boston Healthcare System
Jamaica Plain, MA

Dr. Weber, Course Director, is a consultant for Allergan and Karos Pharmaceuticals.

Albena Halpert, MD
Consultant Faculty
Assistant Professor
Section of Gastroenterology
Boston University School of Medicine
Boston, MA

Dr. Halpert, Consultant Faculty, is a consultant for Allergan.

Planning Committee Disclosures

Rachel Bereiweriso, NP, MSN, Nursing Course Advisor, Boston University School of Medicine Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Michael Burk, Senior Program Manager, Boston University School of Medicine Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Christopher Drury, consultant medical editor, Boston University School of Medicine Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Dana Frazier, Program and Grant Manager, Boston University School of Medicine Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Bret Lashner, MD, Co-Course Director, Boston University School of Medicine Office of Continuing Medical Education and Professor of Medicine at the Cleveland Clinic, has no relevant financial relationships to disclose.

Carmela Townsend, Lead Nurse Planner, Boston University School of Medicine Office of Continuing Medical Education, has no relevant financial relationships to disclose.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.25

Type

CNE Contact Hour(s)

Accreditation Statement

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This enduring material designates 1.25 CNE Contact Hours, all of which are eligible for pharmacology credit.

Disclosure of Unlabeled Use

The unlabeled/investigational uses of commercial products will be discussed in this activity.

For IBS-D off-label discussion of probiotics, loperamide, diphenoxylate-atropine, smooth muscle antispasmodics, tricyclic antidepressants, antibiotics and bile salts (cholestyramine) will be included. For IBS-C off-label discussion of fiber supplementation, laxatives, plecanatide (CIC), antispasmodics, SSRI/SNRI and behavioral therapies.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.

Instructions

By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.25 AMA PRA Category 1 CreditTM  and nurses are entitled to receive 1.25 CNE contact hours. Statements of credit will be available to print immediately. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

  • Complete the post-test and activity evaluation.
  • Physicians and nurses who successfully complete the post-test and evaluation will respectively receive CME. You must score with a 70% or higher on the post-test to receive credit for this activity.
  • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.
Add to Queue